跳至主要内容
临床试验/EUCTR2009-010189-48-IT
EUCTR2009-010189-48-IT进行中(未招募)1 期

Randomised trial comparing the introduction of an immediate or deferred new HAART regimen in failing HIV infected patients: the role of lamivudine monotherapy - ND

OSPEDALE S. RAFFAELE0 个研究点目标入组 280 人开始时间: 2009年2月9日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • adukt patients affected by HIV in unchanged antiretroviral therapy from at least 12 weeks, in virologic failure with HI84V mutation
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • positivity for Hb3AQ; active opportunistic infections; pregnancy;

研究者

发起方
OSPEDALE S. RAFFAELE

相似试验